ArticleJournal of biomedical science2015

Pyrrolidinyl caffeamide against ischemia/reperfusion injury in cardiomyocytes through AMPK/AKT pathways.

Shih-Yi Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.